Searched for
ABBOT LABORATORIES
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...- Bombay HC grants temporary relief to HUL in case against Abbott AdsThe Bombay High Court has directed Abbott Laboratories to halt advertisements that allegedly disparage Hindustan Unilever’s Horlicks Diabet...
- Prefer niche pharma cos to those in generic space: Devang Mehta, Centrum WealthWe have stayed underweight on Sun Pharma, Lupin and Dr Reddy’s, says Mehta
- ISRO trying to put electric propelling system for satellites: SivanVikram Sarabhai Space Centre director Dr K. Sivan said that efforts are on to put electric propelling system for satellites to enable them ...
- Government to commission study on impact of FDI in pharmaceutical companiesThe government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies
- Cabinet defers consideration of pharma, housing FDI proposalsThe Cabinet today deferred the consideration of proposals to relax foreign direct investment norms in the housing sector and to reduce the ...
- Is FDI in pharma giving desired results, wonders DIPPThe DIPP said current norms must lay down the foundation of what should be the nature of Indian drug companies in the long term.
- Govt to finalise FDI policy in pharma before FIPB meetThe government is likely to finalise FDI policy with regard to existing drug companies ahead of the FIPB meeting on July 5.
- DIPP wants relook of FDI policy in pharma at PM levelWith no let up in multinationals seeking nod to acquire stake in Indian pharma firms despite government putting norms to check it.
- FDI in pharma sector faces fresh headwinds with DIPPDepartment of Industrial Policy and Promotion seeks review of the policy barely months after it was cleared at the intervention of the PM.
- Ajay Piramal relies on four teams to scout for buys in pharma, life sciences & real estateIndUS Growth Partners is one of the four entities that Piramal has created to identify opportunities for M&A across sectors.
- Let all pharmaceutical mergers and acquisitions be cleared by CCI: Plan panel groupA Planning Commission expert group recommended that all M&As in the pharma industry should be cleared by CCI.
- Review on FDI in Indian pharma sector soon, says Pranab MukherjeeAmidst a debate whether FDI in pharma sector should be regulated ,Pranab Mukherjee said a decision on the issue would be taken.
- Piramal Healthcare stock plunges on realty planIt announced acquisition of IndiaReit Fund Advisors and IndiaReit Investment Managers for an aggregate of 225 crore.
- Ministers' panel to look into FDI in pharma sectorThe immediate trigger for the move was the acquisition of Ahmedabad-based Paras Pharmaceuticals by British consumer goods and healthcare fi...
- FDI curbs on only govt-aided pharma cosThe government has clarified that FDI in greenfield pharmaceutical projects will continue unhindered, but companies that receive government...
- India rejects Abbot lab's patent application for HIV drugIndia has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving ...
- India-led M&As touch $40 billion in January-June 2010Takeovers by Abbot Labs, Bharti Airtel helped M & A's quadruple in the first half of this year from a year ago. Gainers, losers & recos | T...
- Ranbaxy recieves US approval for anti-bacterial drugUS Food and Drug Administration's has given the approval to manufacture and market anti-bacterial drug oral Clarithromycin in multiple stre...
- Dabur to buy cancer drug business of S Asian coDabur Pharma, the subsidiary of Dabur India, is set to acquire the cancer drug business of a South Asian pharmaceutical company.
Load More
